Description
Regorafenib has multi-action potential wherein it stops various proteins involved in,
- Growth and multiplication of cancer cells (Cell-proliferation)
- Normal functioning of cancer cells (Cell-stability)
- Progression of cancer cells (Oncogenesis)
- Blood flow to cancer cells (Angiogenesis)
Additionally, Resihance 40 mg (Regorafenib) is also specified for patients with liver cancer and gastrointestinal stromal tumors (Cancer of stomach and intestine) who were given prior anti-cancer therapies.
Most common side-effects of Resihance 40 mg (Regorafenib):/h2>
- Problems in the stomach like diarrhea and intestinal infection
- Skin reactions like rashes and HFSR
- Low levels of platelets (Thrombocytopenia)
- Low levels of red blood cells (Anemia)
- Tiredness or fatigue (Asthenia)
- Loss of hunger leading to inadequate food intake and weight loss
- Harsh voice (Dysphonia)
- High blood pressure
- Inflammation in the mouth (Stomatitis)
- Ulcer in the mouth (Mucositis)
